sHLA-G Involved in the Apoptosis of Decidual Natural Killer Cells Following Toxoplasma gondii Infection

Inflammation

Volumn 37, Issue 5, 2014, Pages 1718-1727

  Han, Meiyu ^a   Jiang, Yuzhu ^a   Lao, Kaixue ^a   Xu, Xiaoyan ^a   Zhan, Shaowei ^a   Wang, Yanlin ^a   Hu, Xuemei ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

abnormal pregnancy outcomes; apoptosis; decidual natural killer cells; sHLA G; Toxoplasma gondii

Indexed keywords

CASPASE 3; CASPASE 8; HLA G ANTIGEN;

APOPTOSIS; ARTICLE; COCULTURE; CONTROLLED STUDY; DECIDUA; FEMALE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; TACHYZOITE; TOXOPLASMOSIS; TROPHOBLAST; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; TUMOR CELL LINE;

TOXOPLASMA GONDII;

APOPTOSIS; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DECIDUA; FEMALE; HLA-G ANTIGENS; HUMANS; KILLER CELLS, NATURAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TOXOPLASMOSIS;

EID: 84918796350     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9900-7     Document Type: Article

References (29)

1. Montoya, J.G., and O. Liesenfeld. 2004. Toxoplasmosis. Lancet 363: 1965–1976.
2. Robbins, J.R., V.B. Zeldovich, A. Poukchanski, J.C. Boothroyd, and A.I. Bakardjiev. 2012. Tissue barriers the human placenta to infection with Toxoplasma gondii. Infection and Immunity 80: 418–428.
3. Cecati, M., S.R. Giannubilo, M. Emanuelli, A.L. Tranquilli, and F. Saccucci. 2011. HLA-G and pregnancy adverse outcomes. Medical Hypotheses 76: 782–784.
4. Rizzo, R., A.S. Andersen, M.R. Lassen, H.C. Sørensen, T. Bergholt, M.H. Larsen, L. Melchiorri, M. Stignani, O.R. Baricordi, and T.V. Hviid. 2009. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. American Journal of Reproductive Immunology 62: 320–338.
5. Fuji, T., A. Ishitani, and D.E. Geraghty. 1994. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology 153: 5516–5524.
6. Paul, P., F.A. Cabestre, E.C. Ibrahim, S. Lefebvre, I. Khalil-Daher, G. Vazeux, et al. 2000. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6 and -G7 transcripts in human transfected cells. Human Immunology 61: 1138–4.
7. Carosella, E.D., P. Moreau, J. Le Maoult, M. Le’Discorde, J. Dausset, and N. Rouass-Freiss. 2003. HLA-G molecules: from maternal–fetal tolerance to tissue acceptance. Advances in Immunology 81: 199–252.
8. O’Brien, M., J. Dausset, E.D. Carosella, and P. Moreau. 2000. Analysis of the role of HLA-G in preeclampsia. Human Immunology 61: 1126–1131.
9. Ponte, M., C. Cantoni, R. Biassoni, L. Moretta, M.C. Mingari, et al. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proceedings of the National Academy of Sciences of the United States of America 96: 5674–5679.
10. Carosella, E.D., P. Moreau, S. Aractingi, and N. Rouas-Freiss. 2001. HLA-G: a shield against inflammatory aggression. Trends in Immunology 22: 553–555.
11. Yie, S.M., L.H. Li, Y.M. Li, and C. Librach. 2004. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. American Journal of Obstetrics and Gynecology 191: 525–529.
12. Hackmon, R., A. Koifman, H. Hyodo, H. Glickman, E. Sheiner, and D.E. Geraghty. 2007. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. American Journal of Obstetrics and Gynecology 97(255): e1–e5.
13. Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nature Reviews Immunology 6: 584–594.
14. Bulmer, J.N., P.J. Williams, and G.E. Lash. 2010. Immune cells in the placental bed. International Journal of Developmental Biology 54: 281–294.
15. Santoni, A., A. Zingoni, C. Cerboni, and A. Gismondi. 2007. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. American Journal of Reproductive Immunology 58: 280–288.
16. bright natural killer cells in the human early pregnancy decidua. International Immunology 5: 559–563.
17. Lindaman, A., A. Dowden, and N. Zavazava. 2006. Soluble HLA-G molecules induce apoptosis in natural killer cells. American Journal of Reproductive Immunology 56: 68–76.
18. Strasser, A., P.J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180–192.
19. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nature Reviews Immunology 2: 656–663.
20. Manaster, I., and O. Mandelboim. 2008. The unique properties of human NK cells in the uterine mucosa. Placenta 29: S60–S66.
21. Hanna, J., and O. Mandelboim. 2007. When killers become helpers. Trends in Immunology 28: 201–206.
22. Persson, C.M., H. Lambert, P.P. Vutova, I. Dellacasa-Lindberg, J. Nederby, H. Yagita, H.G. Ljunggren, A. Grandien, A. Barragan, and B.J. Chambers. 2009. Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infection and Immunity 77: 970–976.
23. Solier, C., M. Aguerre-Girr, F. Lenfant, A. Campan, A. Berrebi, V. Rebmann, H. Grosse-Wilde, and P. Le Bouteiller. 2002. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. European Journal of Immunology 32: 3576–3586.
24. Rebmann, V., K. Pfeiffer, M. Pässler, S. Ferrone, S. Maier, E. Weiss, and H. Grosse-Wilde. 1999. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53: 14–22.
25. Jassem, R.M., W.S. Shani, D.A. Loisel, M. Sharief, C. Billstrand, and C. Ober. 2012. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Human Immunology 73: 811–817.
26. Zavazava, N. 1998. Soluble HLA, class I molecules: biological significance and clinical implications. Molecular Medicine Today 4: 116–121.
27. Le Bouteiller, P. 2004. The role of HLA-G expression in the embryo during implantation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris) 33: S9–S12.
28. Nagata, S. 1994. Fas and Fas ligand: a death factor and its receptor. Advances in Immunology 57: 129–144.
29. Peter, M.E., F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.M. Debatin, and P.H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase-8) to the CD95 death-inducing signaling complex. European Journal of Immunology 27: 1207–1212.